GE HealthCare Technologies Inc. (GEHC) — Fair Value Analysis
Base-case fair value (P50): $94.33 · Current price: $65.56 · Verdict: Undervalued
The Verdict on GEHC
Our Monte Carlo simulations indicate GE HealthCare Technologies Inc (GEHC) is currently undervalued, presenting a compelling opportunity based on its median fair value. With GEHC trading at $65.56, our analysis suggests a P50 fair value of $94.33, implying a significant +43.9% upside from its current market price. This verdict is derived from thousands of simulated forward scenarios, providing a probabilistic view of the company's intrinsic worth. The divergence between the current market price and our simulated fair value highlights GEHC as a name to watch for potential appreciation, driven by fundamental projections rather than short-term market noise.
How GEHC stacks up against peers
Despite the undervalued assessment, GEHC’s operational and financial health is currently rated as an average quality tier relative to its sector. This suggests that while there is strong upside potential to our $94.33 fair value from $65.56, its fundamental quality, when compared to industry peers, is neither a standout strength nor a significant weakness. The +43.9% potential, therefore, primarily reflects the market's current underappreciation of GEHC's future cash flows and earnings prospects, rather than a premium on exceptional operational outperformance versus competitors.
What this means for investors
For investors, the undervalued status of GEHC, coupled with an average quality tier, signals a potential opportunity for capital appreciation. The substantial +43.9% from the current $65.56 to our $94.33 fair value suggests that the market may not be fully pricing in GEHC's projected financial trajectory. While our analysis points to clear upside, understanding the full distribution of outcomes, including downside scenarios and bull cases, is crucial. Sign up for a free FairCurve account to see the full bear/bull distribution and track GEHC's fair value as new fundamentals are released.
Frequently Asked Questions
Is GEHC overvalued or undervalued right now?
Based on our Monte Carlo simulations, GE HealthCare Technologies Inc (GEHC) is currently undervalued. Our median fair value (P50) for GEHC is $94.33, while its current price is $65.56.
What is the bear case and bull case for GEHC?
The full Monte Carlo distribution, including bear (P10) and bull (P90) target prices, along with the probability of upside, is available with a free FairCurve account.
How does FairCurve calculate GEHC's fair value?
FairCurve calculates GEHC's fair value using sophisticated Monte Carlo simulations that project thousands of forward scenarios to determine a probabilistic range of intrinsic values.
How can I track GEHC's fair value as it changes?
Add GEHC to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuations whenever new earnings or financial fundamentals are released.